Stephen K Doberstein - Net Worth and Insider Trading
Stephen K Doberstein Net Worth
The estimated net worth of Stephen K Doberstein is at least $135,662 dollars as of 2024-09-20. Stephen K Doberstein is the SVP & Chief Scientific Officer of Nektar Therapeutics and owns about 107,668 shares of Nektar Therapeutics (NKTR) stock worth over $135,662. Details can be seen in Stephen K Doberstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen K Doberstein has not made any transactions after 2019-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen K Doberstein
Stephen K Doberstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen K Doberstein owns 3 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , Nektar Therapeutics (NKTR) , and Forte Biosciences Inc (FBRX) .
Click here to see the complete history of Stephen K Doberstein’s form 4 insider trades.
Insider Ownership Summary of Stephen K Doberstein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DRNA | Dicerna Pharmaceuticals Inc | 2020-06-15 | director |
NKTR | Nektar Therapeutics | 2019-09-05 | Chief Scientific Officer |
FBRX | Forte Biosciences Inc | 2022-05-12 | director |
Stephen K Doberstein Latest Holdings Summary
Stephen K Doberstein currently owns a total of 1 stock. Stephen K Doberstein owns 107,668 shares of Nektar Therapeutics (NKTR) as of September 5, 2019, with a value of $135,662.
Latest Holdings of Stephen K Doberstein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NKTR | Nektar Therapeutics | 2019-09-05 | 107,668 | 1.26 | 135,662 |
Holding Weightings of Stephen K Doberstein
Stephen K Doberstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen K Doberstein has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the acquisition of 15,000 shares on September 5, 2019, which cost Stephen K Doberstein around $259,200.
Insider Trading History of Stephen K Doberstein
- 1
Stephen K Doberstein Trading Performance
GuruFocus tracks the stock performance after each of Stephen K Doberstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen K Doberstein is 14.34%. GuruFocus also compares Stephen K Doberstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen K Doberstein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen K Doberstein's insider trading performs compared to the benchmark.
Performance of Stephen K Doberstein
Stephen K Doberstein Ownership Network
Stephen K Doberstein Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Stephen K Doberstein is the director of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
Stephen K Doberstein Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen K Doberstein. You might contact Stephen K Doberstein via mailing address: 129 Elsie Street, San Francisco Ca 94110.